PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Clinical Immunology, Auckland Hospital, Grafton Auckland, New Zealand.\', \'Department of Virology and Immunology, Auckland Hospital, Grafton, Auckland, New Zealand.\', \'Department of Molecular Medicine and Pathology, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zealand.\', \'Department of Medicine, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, New Zeland.\', \'Auckland Cancer Society Research Centre, School of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.\', \'Department of Respiratory Medicine, Wellington Hospital, Wellington, New Zealand.\', \'School of Biological Sciences and Center for Brain Research, University of Auckland, Symonds St, Auckland, New Zealand.\', \'Maurice Wilkins Centre, University of Auckland, New Zealand.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/1744666X.2021.1905525
?:hasPublicationType
?:journal
  • Expert review of clinical immunology
is ?:pmid of
?:pmid
?:pmid
  • 33745411
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.097
?:rankingScore_hIndex
  • 38
is ?:relation_isRelatedTo_publication of
?:title
  • Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all